Sunesis Pharma (SNSS) Tops Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Join SI Premium – FREE
Sunesis Pharma (NASDAQ: SNSS) reported Q3 EPS of ($0.62), $0.09 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $600 thousand versus the consensus estimate of $600 thousand.
For earnings history and earnings-related data on Sunesis Pharma (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
